| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +101.9% | |
| Gross profit | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | −101.9% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 2.4 | 4.3 | 2.7 | 4.3 | 6.7 | 4.6 | −31.8% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 2.4 | 11.0 | 2.7 | 3.7 | 5.8 | 4.6 | −20.7% | |
| Operating income | (2.4) | (11.0) | (2.7) | (3.7) | (5.8) | (4.6) | +20.6% | |
| Interest expense | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | +140.7% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.2 | +114.4% | |
| Other income / expense | 0.0 | (0.6) | 0.1 | (5.7) | 0.1 | 0.4 | +358.5% | |
| Pre-tax income | (2.4) | (11.6) | (2.6) | (9.3) | (5.7) | (4.2) | +26.6% | |
| Income tax | (0.8) | (6.9) | 0.0 | 0.0 | 0.0 | 0.0 | −3.3% | |
| Net income | (1.6) | (4.7) | (15.5) | (4.2) | (16.4) | (4.2) | +74.7% | |
| Discontinued operations | 0.0 | 0.0 | (12.9) | 5.1 | (10.8) | 0.0 | +100.0% | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.16) | (0.13) | (0.27) | (0.07) | (0.29) | (0.07) | +77.2% | |
| EPS, diluted (per share) | (0.16) | (0.13) | (0.27) | (0.07) | (0.29) | (0.07) | +77.2% | |
| EBITDA | (2.4) | (11.4) | (2.6) | (3.8) | (5.7) | (4.4) | +22.9% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +101.9% | |
| Weighted average shares (shares) | 10,000,000 | 36,082,191 | 56,666,665 | 56,670,294 | 57,545,029 | 63,048,073 | +9.6% | |
| Weighted average diluted shares (shares) | 10,000,000 | 36,082,191 | 56,666,665 | 60,098,863 | 57,545,029 | 63,048,073 | +9.6% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
